Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.

about

Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.

Item

http://www.wikidata.org/entity/Q54117757

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cyclic Guanosine Monophosphate ...... Effects on Osteosarcoma Cells.

@en

Cyclic Guanosine Monophosphate

@nl

type

Item

label

Cyclic Guanosine Monophosphate ...... Effects on Osteosarcoma Cells.

@en

Cyclic Guanosine Monophosphate

@nl

prefLabel

Cyclic Guanosine Monophosphate ...... Effects on Osteosarcoma Cells.

@en

Cyclic Guanosine Monophosphate

@nl

P1476

Cyclic Guanosine Monophosphate ...... Effects on Osteosarcoma Cells

@en

P2093

Dapeng Li

http://www.w3.org/2001/XMLSchema#string

Jiawei Yue

http://www.w3.org/2001/XMLSchema#string

Lu Jiang

http://www.w3.org/2001/XMLSchema#string

Yan Wu

http://www.w3.org/2001/XMLSchema#string

Ye Hua

http://www.w3.org/2001/XMLSchema#string

Yongchang Chen

http://www.w3.org/2001/XMLSchema#string

Yonghui Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

EGFR expression in gallbladder carcinoma in North America.

Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway.

PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells

Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition

Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.

Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis

P304

1997-2002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.905892

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29617357

http://www.w3.org/2001/XMLSchema#string

P932

5900801

http://www.w3.org/2001/XMLSchema#string